|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2827 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/2896 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K2039/505 | (2013.01) |
| (11) | Patento numeris | 3433273 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17713672.8 |
| Europos patento paraiškos padavimo data | 2017-03-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/057220 |
| Data | 2017-03-27 |
| (87) | Numeris | WO 2017/162890 |
| Data | 2017-09-28 |
| (30) | Numeris | Data | Šalis |
| 16305350 | 2016-03-25 | EP |
| (72) |
ZHUKOVSKY, Eugene , FR
LEGER, Olivier , FR
MORSE, Richard J. , FR
|
| (73) |
Biomunex Pharmaceuticals ,
113 rue de la Tour, 75116 Paris,
FR
|
| (54) | BINDING MOLECULES TO CD38 AND PD-L1 |
| BINDING MOLECULES TO CD38 AND PD-L1 |